メタボロミクスの世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Global Metabolomics Market 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Biomarker and drug discovery – Market size and forecast 2018-2023
• Nutrigenomics – Market size and forecast 2018-2023
• Toxicology testing – Market size and forecast 2018-2023
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Increasing applications of metabolomics
• High potential for new techniques in metabolomics
• New developments in the field of metabolomics
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies
• Bio-Rad Laboratories
• Bruker
• Human Metabolome Technologies
• METABOLON
PART 13: APPENDIX
• Research methodology
• List of abbreviations

Exhibit 01: Years in consideration
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Application – Market share 2018-2023 (%)
Exhibit 19: Comparison by application
Exhibit 20: Biomarker and drug discovery – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Biomarker and drug discovery – Year-over-year growth 2019-2023 (%)
Exhibit 22: Nutrigenomics – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Nutrigenomics – Year-over-year growth 2019-2023 (%)
Exhibit 24: Toxicology testing – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Toxicology testing – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 34: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 36: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Decision framework
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Agilent Technologies – Vendor overview
Exhibit 48: Agilent Technologies – Business segments
Exhibit 49: Agilent Technologies – Organizational developments
Exhibit 50: Agilent Technologies – Geographic focus
Exhibit 51: Agilent Technologies – Segment focus
Exhibit 52: Agilent Technologies – Key offerings
Exhibit 53: Bio-Rad Laboratories – Vendor overview
Exhibit 54: Bio-Rad Laboratories – Business segments
Exhibit 55: Bio-Rad Laboratories – Organizational developments
Exhibit 56: Bio-Rad Laboratories – Geographic focus
Exhibit 57: Bio-Rad Laboratories – Segment focus
Exhibit 58: Bio-Rad Laboratories – Key offerings
Exhibit 59: Bruker – Vendor overview
Exhibit 60: Bruker – Business segments
Exhibit 61: Bruker – Organizational developments
Exhibit 62: Bruker – Geographic focus
Exhibit 63: Bruker – Segment focus
Exhibit 64: Bruker – Key offerings
Exhibit 65: Human Metabolome Technologies – Vendor overview
Exhibit 66: Human Metabolome Technologies – Business segments
Exhibit 67: Human Metabolome Technologies – Organizational developments
Exhibit 68: Human Metabolome Technologies – Key offerings
Exhibit 69: METABOLON – Vendor overview
Exhibit 70: METABOLON – Business segments
Exhibit 71: METABOLON – Organizational developments
Exhibit 72: METABOLON – Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: List of abbreviations



【レポート販売概要】

■ タイトル:メタボロミクスの世界市場2019-2023
■ 英文:Global Metabolomics Market 2019-2023
■ 発行日:2019年1月23日
■ 調査会社:Technavio
■ 商品コード:IRTNTR30731
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。